Confirming Elevated Breath Alkanes in Ulcerative Colitis and Crohn's

Earlier breath studies in inflammatory bowel disease (IBD) faced a technical problem: pentane, a marker of oxidative stress, overlapped with another compound called isoprene on standard equipment, raising doubts about whether the “pentane” signal was real. This 1999 study set out to settle the question.

What the researchers did

The University of Perugia team studied 20 patients with active IBD — 10 with ulcerative colitis and 10 with Crohn’s disease — plus healthy controls. Crucially, they used a specialized chromatography column able to cleanly separate pentane from isoprene, then measured exhaled ethane, propane, pentane, butane, and isoprene.

What they found

• Ethane, propane, and pentane were significantly elevated in IBD patients compared with controls.
• Butane and isoprene showed no significant difference.
• The pentane elevation was confirmed as genuine, not a chromatographic artifact — the first rigorous proof of this.
• Both ulcerative colitis and Crohn’s patients showed elevated alkanes, even though all were already on steroid and anti-inflammatory medication.

“Isoprene was clearly distinguished from pentane, demonstrating that the significant elevation of pentane levels in patients with inflammatory bowel diseases was a real phenomenon and not an artifact caused by coelution with isoprene.”

“An excess of lipid peroxidation is probably an important pathogenetic factor in inflammatory bowel diseases, and this may be assessed through a noninvasive method.”

Why it matters

By proving the signal was authentic, this study cemented breath alkanes as a credible, non-invasive reflection of gut inflammation. It supports a central theme in gut science: the chemistry the body emits genuinely mirrors inflammatory activity inside the digestive tract. It is a research finding about disease activity, not a self-test for diagnosis.